Synlogic Inc

NASDAQ:SYBX  
2.26
-0.11 (-4.64%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)157.55M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.17 Million
Adjusted EPS-$0.27
See more estimates
10-Day MA$2.46
50-Day MA$2.69
200-Day MA$3.27
See more pivots

Synlogic Inc Stock, NASDAQ:SYBX

301 Binney Street, Suite 402, Cambridge, Massachusetts 02142
United States of America
Phone: +1.617.401.9975
Number of Employees: 72

Description

Synlogic, Inc. engages in the discovery and development of Synthetic Biotic medicines. It focuses in Phenylketonuria, Enteric Hyperoxaluria, Immuno Oncology solid tumors, inflammatory bowel disease, and vaccines and other inflammatory programs. The company was founded by Jim Collins and Tim Lu on August 28, 2017, and is headquartered in Cambridge, MA.